We hypothesized that AHRR (cg05575921) hypomethylation, as a strong biomarker of long-term smoking behavior, offers additional information beyond that offered by self-reported smoking to identify lung cancer patients that specifically benefits from therapy. Here, AHRR is linked to lung cancer.